2017
DOI: 10.1024/0301-1526/a000624
|View full text |Cite
|
Sign up to set email alerts
|

Very distal vein bypass in patients with thromboangiitis obliterans

Abstract: Summary:Background: Surgical revascularization for chronic critical limb ischaemia in patients with thromboangiitis obliterans (TAO) still remains controversial. Generally, besides cessation of smoking, conservative treatment supported by intravenous administration of vasoactive agents is regarded as the treatment of choice, in combination with local wound therapy or minor amputation. Patients and methods: In four male patients (42-47 years) surgical revascularization was chosen as therapy for established gang… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…TAO is regarded as a chronic inflammation of the small and medium-sized arteries and veins of both the lower and upper extremities with unknown etiology affecting younger smokers followed by a thrombotic occlusion [ 2 , 3 ]. Although medical treatment and smoking cessation are sometimes sufficient to induce a remission of the ischemic symptoms, resulting in relatively favorable outcomes for the affected limbs in contrast to patients with ASO, the resulting ischemia may lead to severe chronic symptoms such as non-healing ulceration and gangrene, and even major amputation [ 2 , 3 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…TAO is regarded as a chronic inflammation of the small and medium-sized arteries and veins of both the lower and upper extremities with unknown etiology affecting younger smokers followed by a thrombotic occlusion [ 2 , 3 ]. Although medical treatment and smoking cessation are sometimes sufficient to induce a remission of the ischemic symptoms, resulting in relatively favorable outcomes for the affected limbs in contrast to patients with ASO, the resulting ischemia may lead to severe chronic symptoms such as non-healing ulceration and gangrene, and even major amputation [ 2 , 3 ].…”
Section: Resultsmentioning
confidence: 99%
“…TAO is regarded as a chronic inflammation of the small and medium-sized arteries and veins of both the lower and upper extremities with unknown etiology affecting younger smokers followed by a thrombotic occlusion [ 2 , 3 ]. Although medical treatment and smoking cessation are sometimes sufficient to induce a remission of the ischemic symptoms, resulting in relatively favorable outcomes for the affected limbs in contrast to patients with ASO, the resulting ischemia may lead to severe chronic symptoms such as non-healing ulceration and gangrene, and even major amputation [ 2 , 3 ]. In patients with TAO in jeopardy of losing a foot or leg, a more aggressive therapeutic option, either endovascular or surgical procedure, is required to not only avoid major amputation (allowing a return to ambulation) but also to stabilize the socioeconomic situation (allowing a return to work) of these relatively young patients [ 14 ].…”
Section: Resultsmentioning
confidence: 99%
“…Thromboangiitis obliterans (TAO) is a chronic occlusive disease characterized by segmental, non-suppurative inflammation, and intravascular thrombus formation (1). It mainly invades the limbs, especially the small and medium arteries and veins of the lower limbs, and then causes ischemic changes in the distal side of the affected limb (2).…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, it has been shown that the prevalence of TAO in women has also increased, reaching 11-23% ( 2 ). Early TAO manifests as ischemic symptoms, and in the advanced stage, symptoms such as limb ulcers and gangrene appear ( 3 ). Although there is a detailed understanding of the occurrence and development of TAO, TAO has the characteristics of being difficult to cure clinically.…”
Section: Introductionmentioning
confidence: 99%